TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Epsilon Healthcare Limited ( (AU:EPN) ) has shared an announcement.
Epsilon Healthcare Limited announced a change in the director’s interest, with Peter Giannopoulos acquiring 25,000,000 unlisted options. These options, issued to lenders under a DOCI approved at an EGM, are set to expire on 24 June 2028 with an exercise price of $0.02 or the TERP of any future capital raise. This change in director’s interest signifies a strategic move in the company’s financial management and could impact the company’s market positioning and stakeholder interests.
More about Epsilon Healthcare Limited
Epsilon Healthcare Limited operates in the healthcare industry, focusing on providing healthcare services and products. The company is involved in various aspects of healthcare, potentially including pharmaceuticals, medical devices, or health services, aiming to address the needs of patients and healthcare providers.
Technical Sentiment Signal: Sell
Current Market Cap: A$7.21M
See more data about EPN stock on TipRanks’ Stock Analysis page.